# K150660: Alcyone MEMS Cannula (AMC) System

- Pathway: 510(k) (Traditional)
- Applicant: Alcyone Lifesciences, Inc.
- Decided: Apr 16, 2015 after 34 days
- Product code: HCD (Cannula, Ventricular)
- Device class: 1
- Regulation: 21 CFR 882.4060
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K102101 (2011). 1 ancestor in all.
1 later device descends from it; 1 cites it directly.
0 of 3 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K102101: Surgivision MR Compatible Ventricular Cannula, Surgivision, Inc. (2011) Summary page 4.

## Most influential descendants
- K161731: Cleveland Multiport Ventricular Catheter Set (2017), 0 descendants of its own

## Indications for use
The Alcyone MEMS Cannula (AMC) System consisting of the AMC and the AMC Extension Line Set, is intended for injection of Cytarabine (cytosine arabinoside) or removal of cerebrospinal fluid (CSF) from the ventricles of the brain during intracranial procedures. The AMC System is not intended for implant. The device is intended for "single patient use only."

Source page: https://510kreport.com/device/K150660
Methodology: https://510kreport.com/methodology
